1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: US AI in Medical Imaging Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. US AI in Medical Imaging Market, by Technology
8.1.1. Deep Learning
8.1.1.1. Market Revenue and Forecast
8.1.2. Natural Language Processing (NLP)
8.1.2.1. Market Revenue and Forecast
8.1.3. Other
8.1.3.1. Market Revenue and Forecast
9.1. US AI in Medical Imaging Market, by Application
9.1.1. Neurology
9.1.1.1. Market Revenue and Forecast
9.1.2. Respiratory and Pulmonary
9.1.2.1. Market Revenue and Forecast
9.1.3. Cardiology
9.1.3.1. Market Revenue and Forecast
9.1.4. Breast Screening
9.1.4.1. Market Revenue and Forecast
9.1.5. Orthopedics
9.1.5.1. Market Revenue and Forecast
10.1. US AI in Medical Imaging Market, by Modalities
10.1.1. CT Scan
10.1.1.1. Market Revenue and Forecast
10.1.2. MRI
10.1.2.1. Market Revenue and Forecast
10.1.3. X-rays
10.1.3.1. Market Revenue and Forecast
10.1.4. Ultrasound
10.1.4.1. Market Revenue and Forecast
10.1.5. Nuclear Imaging
10.1.5.1. Market Revenue and Forecast
11.1. US AI in Medical Imaging Market, by End Use
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast
11.1.2. Diagnostic Imaging Centers
11.1.2.1. Market Revenue and Forecast
11.1.3. Others
11.1.3.1. Market Revenue and Forecast
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Technology
12.1.5.2. Market Revenue and Forecast, by Application
12.1.5.3. Market Revenue and Forecast, by Modalities
12.1.5.4. Market Revenue and Forecast, by End Use
13.1. GE HealthCare
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Microsoft
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Digital Diagnostics Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. TEMPUS
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Butterfly Network, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Advanced Micro Devices, Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. HeartFlow, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Enlitic, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Canon Medical Systems USA, Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Viz.ai, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
